Chronic Myelogenous Leukemia in a 66-Year-Old Male with Concurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

被引:0
作者
Szymanski, Linda J. [1 ]
Ayyad, Hashem [1 ]
Inamdar, Kedar [1 ]
机构
[1] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA
来源
LABMEDICINE | 2013年 / 44卷 / 02期
关键词
flow cytometry; hematology; hematopathology; molecular diagnostics; CHRONIC MYELOID-LEUKEMIA; DASATINIB; PATIENT;
D O I
10.1309/LM5JS4LSSLX7UQYV
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Patient: A 66-year-old Caucasian male. Chief Complaint: The patient felt tired and was eating less than usual. Previously, the patient could ride his bike for 3 miles, but now can barely complete 1 mile. Medical History: Significant for persistent lymphocytosis for the past 10 years and recently diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) by flow cytometry on peripheral blood. He also has a history of hyperlipidemia, diabetes mellitus, and obstructive sleep apnea. Social History: The patient does not smoke or use illicit drugs. He uses alcohol occasionally. The patient is married and is retired from an automobile supply company. Family History: Noncontributory. None of his family members have a history of blood disorders. Physical Examination: Significant for the following: alert; oriented to time, place, and person; neck: no palpable lymphadenopathy; heart and lung: unremarkable; abdomen: obese and soft, no palpable hepatosplenomegaly. Vital signs: Blood pressure: 137/58 mmHg; pulse: 68/minute; respiratory rate: 12/minute; temperature: 37 C. Principal Laboratory Findings: Laboratory test results are in Table 1. Additional Testing: The molecular diagnostic test Janus kinase 2 (JAK2) V617F mutation was ordered. A peripheral blood smear at the hematologist's office was abnormal 3 months later. Subsequently, on the peripheral blood specimen the molecular test assessing presence of BCR/ABL1 mRNA transcript producing the 210-kDa protein (p210) was ordered and a bone marrow biopsy with aspirate was performed. The bone marrow aspirate was also submitted for morphologic, cytogenetic, and flow cytometric evaluations (Images 1 and 2).
引用
收藏
页码:142 / 146
页数:5
相关论文
共 12 条
[11]  
Vardiman JW., 2008, WHO CLASSIFICATION T
[12]   The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVHgenes [J].
Veldurthy, Aditya ;
Patz, Michaela ;
Hagist, Susanne ;
Pallasch, Christian P. ;
Wendtner, Clemens-Martin ;
Hallek, Michael ;
Krause, Guenter .
BLOOD, 2008, 112 (04) :1443-1452